CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ (40,233)	$ (34,522)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	111,525	102,893
Amortization	24,089	24,327
Deferred income tax (benefit) expense	5,634	3,946
Equity (income) loss of unconsolidated entities, net	84	593
Dividends from unconsolidated entities	204	0
Impairment of Long-Lived Assets to be Disposed of	0	14,099
Remeasurement of long-lived assets	10,695	0
Gain on sale of businesses, net	(10,478)	0
Other, net	1,928	4,743
Changes in assets and liabilities, net of acquisitions and dispositions of businesses:
Accounts receivable	3,231	(48,175)
Inventories	(17,084)	(10,548)
Contract assets	(14,923)	1,317
Right-of-use assets	23,687	24,467
Accounts payable	7,421	(818)
Accrued interest payable	(5,092)	(6,828)
Accrued compensation	(13,412)	20,436
Advances on contracts	(10,446)	(21,824)
Operating lease liabilities	(23,341)	(22,980)
Retirement plan liabilities, net	(6,981)	(4,862)
Other assets and liabilities	(4,737)	(92)
Net cash (used) provided by operating activities	41,771	46,172
Cash flows from investing activities:
Purchases of property, plant and equipment	(102,094)	(93,630)
Proceeds from sale of business, net	57,667	0
Proceeds from sales of assets	12,479	2,080
Expenditures for intangible assets	(1,181)	(478)
Proceeds from notes receivable	17,023	11,238
Net proceeds (payments) from settlement of foreign currency forward exchange contracts	(6,133)	2,034
Other investing activities, net	0	462
Net cash used by investing activities	(22,239)	(78,294)
Cash flows from financing activities:
Short-term borrowings, net	(2,982)	4,196
Current maturities and long-term debt:
Additions	201,562	185,992
Reductions	(200,584)	(140,522)
Dividends paid to noncontrolling interests	(15,964)	0
Contributions from noncontrolling interests	874	1,654
Stock-based compensation - Employee taxes paid	(1,546)	(1,374)
Deferred financing costs	(3,765)	0
Net cash (used) provided by financing activities	(22,405)	49,946
Effect of exchange rate changes on cash and cash equivalents, including restricted cash	(8,609)	(4,231)
Net increase (decrease) in cash and cash equivalents, including restricted cash	(11,482)	13,593
Cash and cash equivalents, including restricted cash, at beginning of period	124,614	85,094
Cash and cash equivalents, including restricted cash, at end of period	113,132	98,687
Supplementary cash flow information:
Change in accrual for purchases of property, plant and equipment included in accounts payable	$ 3,501	$ (3,252)